Skip to main content

The Growth Hormone/Insulin-Like Growth Factor I Axis During Surgical Stress and Critical Illness

  • Chapter
Acute Catabolic State

Part of the book series: Update in Intensive Care and Emergency Medicine ((UICM,volume 21))

  • 43 Accesses

Abstract

Acquired growth hormone (GH) resistance is found in patients who have malnutrition and protein catabolism in common, such as post-surgical and critically ill patients and patients with organ failure [1]. GH resistance is the finding of high GH levels with low levels of the somatomedin insulin-like growth factor I (IGF I), which mediates the anabolic actions of GH. This may be primary, as in patients with Laron syndrome or acquired GH resistance [2]. There is now a body of evidence to suggest that the changes in the GH/IGF I axis are permissive to protein catabolism and that treatment with either GH and/or IGF I may improve the nutritional state of some patient groups [3].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ross RJM, Mieli JP, Buchanan CR (1991) Avoiding autocannibalism: consider growth hormone and insulin-like growth factor-I. BMJ 303:1147–1148

    Article  PubMed  CAS  Google Scholar 

  2. Laron Z, Blum WF, Chatelain PG et al. (1993) Classification of growth hormone insensitivity syndrome. J Pediatr 122:241

    Article  PubMed  CAS  Google Scholar 

  3. Clemmons DR (1992) Role of insulin like growth factor-I in reversing catabolism. J Clin Endocrinol Metab 75:1183–1185

    Article  PubMed  CAS  Google Scholar 

  4. Rosenfeld RG, Lamson G, Pham H et al. (1993) Insulin-like growth factor-binding proteins. Recent Prog Horm Res 46:99–163

    Google Scholar 

  5. Taylor AM, Dünger ADB, Preece MA et al. (1990) The growth hormone independent insulinlike growth factor-binding protein BP-28 is associated with serum insulin-like growth factor-I inhibitory bioactivity in adolescent insulin-dependent diabetics. Clin Endocrinol (Oxf) 32:229–239

    Article  CAS  Google Scholar 

  6. Lewitt MS, Denyer GS, Conney GJ, Baxter RC (1991) Insulin-like growth factor binding protein-1 modulates blood glucose levels. Endocrinology 129:2254–2256

    Article  PubMed  CAS  Google Scholar 

  7. Blum WF, Horn N, Kratzsch J et al. (1993) Clinical studies of IGFBP-2 by radioimmunoassay. Growth Regul 3:100–104

    PubMed  CAS  Google Scholar 

  8. Blum WF, Ranke MB (1991) Plasma IGFBP-3 levels as clinical indicators. In: Spencer EM (ed) Modern concepts of insulin-like growth factors. Elsevier, New York, pp 381–393

    Google Scholar 

  9. Ross RJM, Freeman E, Jones J, Matthews DR, Preece MA, Buchanan CR (1991) Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-1. Clin Endocrinol (Oxf) 35:47–54

    Article  CAS  Google Scholar 

  10. Ross RJM, Mieli JP, Holly JMP, Maheshware H, Norman M, Abdulla AF, Buchanan CR (1991) Levels of GH, IGF binding proteins, insulin, blood glucose and Cortisol in intensive care patients. Clin Endocrinol (Oxf) 35:361–367

    Article  CAS  Google Scholar 

  11. Ho KY, Veldhuis JD, Johnson ML et al. (1988) Fasting enhance growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man. J Clin Invest 81:968–975

    Article  PubMed  CAS  Google Scholar 

  12. Davies SC, Wass JAH, Ross RJM et al. (1991) The induction of a specific protease for insulin-like growth factor binding protein-3 in the circulation during severe illness. J Endocrinol 130:469–473

    Article  PubMed  CAS  Google Scholar 

  13. Lassarre C, Binoux M (1994) Insulin-like growth factor binding protein-3 is functionally altered in pregnancy plasma. Endocrinology 134:1254–1262

    Article  PubMed  CAS  Google Scholar 

  14. Van Den Berghe G (1994) Dopamine and pituitary hormones in critical illness. Leuven University Press, Leuven

    Google Scholar 

  15. Cotterill AM, Mendel P, Holly JMP et al. (1995) The differential regulation of the circulating levels of the insulin-like growth factors and their binding proteins (IGFBP) 1, 2 and 3 after elective abdominal surgery. Clin Endocrinol (Oxf) (Submitted)

    Google Scholar 

  16. Cuthbertson DP (1931) Observations on the disturbance of metabolism produced by injury to the limbs. Q J Med 2:233–246

    Google Scholar 

  17. Donaghy A, Ross RJM, Gimson AE, Hughes SC, Holly J, Williams R (1995) Growth hormone, insulin-like growth factor-I and insulin-like growth factor binding proteins 1 and 3 in chronic liver disease. Hepatology 21: 680–688

    PubMed  CAS  Google Scholar 

  18. Mendenhall CL, Chernhausek SD, Ray MB et al. (1989) The interactions of insulin-like growth factor-I (IGF-I) with protein-calorie malnutrition in patients with alcoholic liver disease. V.A. Cooperative study on alcoholic hepatitis. Alcohol Alcohol 24:319–329

    PubMed  CAS  Google Scholar 

  19. Ross RJM, Rodriguez-Arnao J, Donaghy A et al. (1994) Expression of IGFBP-1 in normal and cirrhotic human livers. J Endocrinol 141:377–382

    Article  PubMed  CAS  Google Scholar 

  20. Ross RJM, Rodriguez-Arnao J, Wraight CJ, Clark AJL (1994) Expression of IGF-I, IGFBP-1, 2, 3, and GH receptor (GHR) genes in normal liver and cirrhosis. J Endocrinol 140:111

    Article  Google Scholar 

  21. Koea JB, Gallaher BW, Breier BH et al. (1992) Passive immunization against circulating insulin-like growth factor-I (IGF-I) increases protein catabolism in lambs: evidence for a physiological role for circulating IGF-I. J Endocrinol 135:279–284

    Article  PubMed  CAS  Google Scholar 

  22. Wilmore DW (1991) Catabolic illness, strategies for enhancing recovery. N Engl J Med 325:695–702

    Article  PubMed  CAS  Google Scholar 

  23. Mieli JP, Taylor AM, Jones J et al. (1992) Administration of recombinant insulin-like growth factor-I to patients following major gastrointestinal surgery. Clin Endocrinol (Oxf) 37:542–551

    Article  Google Scholar 

  24. Blat C, Villaudy J, Bihoux M (1994) In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells. J Clin Invest 93:2296–2290

    Article  Google Scholar 

  25. Holly JMP, Claffey P, Cwyfan Hughes SC, Frost VJ, Yateman ME (1993) Proteases acting on IGFBPs: their occurrence and physiological significance. Growth Regul 3:88–91

    PubMed  CAS  Google Scholar 

  26. Ross RJM, Buchanan CR (1990) Growth hormone secretion: its regulation and the influence of nutritional factors. Nutrition Res Rev 3:143–162

    Article  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Ross, R.J.M., Cotterill, A.M. (1996). The Growth Hormone/Insulin-Like Growth Factor I Axis During Surgical Stress and Critical Illness. In: Revhaug, A. (eds) Acute Catabolic State. Update in Intensive Care and Emergency Medicine, vol 21. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-48801-6_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-48801-6_25

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-48803-0

  • Online ISBN: 978-3-642-48801-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics